{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:29:09Z","timestamp":1795188549414,"version":"4.10.3"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Whipple's disease (WD), triggered by <jats:italic toggle=\"yes\">Tropheryma whipplei<\/jats:italic> (<jats:italic toggle=\"yes\">T. whipplei<\/jats:italic>), is a rare, chronic, inflammatory, systemic infectious disease that typically manifests in adults. The most frequent initial manifestations include arthritis, followed by diarrhea, abdominal pain, and weight loss. Half the world's population is exposed to <jats:italic toggle=\"yes\">T. whipplei<\/jats:italic>, but only one in a million develop WD. This suggests that acquired or inborn errors of immunity (IEI) may underlie WD. Anti-TNF treatment is a well established risk factor for flare-ups of WD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>We have also reported two rare IEI in patients with WD. Six WD patients from two unrelated kindreds were found to have autosomal dominant IRF4 deficiency acting via a mechanism of haploinsufficiency. These patients were otherwise healthy. In addition, a single patient with a history of WD and other infections was found to have autosomal recessive CD4 deficiency.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Rare IEI can underlie WD. Human genetic studies of patients with WD are warranted for the development of precision medicine for affected kindreds and to improve our understanding of the pathogenesis of this rare infectious disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000001088","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T08:00:08Z","timestamp":1741593608000},"page":"316-320","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Human genetics of Whipple's disease"],"prefix":"10.1097","volume":"37","author":[{"given":"J\u00e9r\u00e9mie","family":"Rosain","sequence":"first","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children"},{"name":"University of Paris Cit\u00e9, Imagine Institute"},{"name":"Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris, France, EU"},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children"},{"name":"University of Paris Cit\u00e9, Imagine Institute"},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University"},{"name":"Howard Hughes Medical Institute, New York, New York, USA"},{"name":"Department of Pediatrics, Necker Hospital for Sick Children, AP-HP, Paris, France, EU"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacinta","family":"Bustamante","sequence":"additional","affiliation":[{"name":"Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Inserm U1163, Necker Hospital for Sick Children"},{"name":"University of Paris Cit\u00e9, Imagine Institute"},{"name":"Study Center for Primary Immunodeficiencies, Necker Hospital for Sick Children, Assistance Publique-H\u00f4pitaux de Paris (AP-HP), Paris, France, EU"},{"name":"St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJM200003023420903","article-title":"Cultivation of the bacillus of Whipple's disease","volume":"342","author":"Raoult","year":"2000","journal-title":"N Engl J Med"},{"key":"R2-20250728","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1101\/gr.1474603","article-title":"Tropheryma whipplei Twist: a human pathogenic Actinobacteria with a reduced genome","volume":"13","author":"Raoult","year":"2003","journal-title":"Genome Res"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200304033481425","article-title":"Immunodetection of Tropheryma whipplei in intestinal tissues from Dr Whipple's 1907 patient","volume":"348","author":"Dumler","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(22)00128-1","article-title":"Whipple's disease and Tropheryma whipplei infections: from bench to bedside","volume":"22","author":"Boumaza","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/annrheumdis-2012-202684","article-title":"Whipple's disease","volume":"72","author":"Pu\u00e9chal","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R6-20250728","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra062477","article-title":"Whipple's disease","volume":"356","author":"Fenollar","year":"2007","journal-title":"N Engl J Med"},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"12278","DOI":"10.1038\/s41598-021-91671-9","article-title":"Rheumatological features of Whipple disease","volume":"11","author":"Tison","year":"2021","journal-title":"Sci Rep"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jbspin.2016.07.001","article-title":"Whipple's arthritis","volume":"83","author":"Pu\u00e9chal","year":"2016","journal-title":"Joint Bone Spine"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/icvts\/ivs116","article-title":"Tropheryma whipplei endocarditis without gastrointestinal involvement","volume":"15","author":"Love","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R10-20250728","first-page":"e238336","article-title":"Valvular endocarditis and biventricular heart failure in the setting of Tropheryma whipplei disease","volume":"51","author":"Ergi","year":"2024","journal-title":"Tex Heart Inst J"},{"key":"R11-20250728","first-page":"e65385","article-title":"An unusual case of limbic encephalitis caused by Whipple disease","volume":"16","author":"Miller","year":"2024","journal-title":"Cureus"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/ICU.0000000000000989","article-title":"Ophthalmic manifestations of Whipple's disease","volume":"35","author":"Rasool","year":"2024","journal-title":"Curr Opin Ophthalmol"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"900589","DOI":"10.3389\/fimmu.2022.900589","article-title":"A massive number of extracellular Tropheryma whipplei in infective endocarditis: a case report and literature review","volume":"13","author":"Hannachi","year":"2022","journal-title":"Front Immunol"},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"104","DOI":"10.5114\/reum.2021.105418","article-title":"Clinical manifestations of Whipple's disease mimicking rheumatic disorders","volume":"59","author":"Kucharz","year":"2021","journal-title":"Reumatologia"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/rheumatology\/keae485","article-title":"Whipple disease diagnosed through minimally invasive ultrasound-guided synovial biopsy","volume":"64","author":"Salvato","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/491745","article-title":"Whipple disease: intestinal infiltrating cells exhibit a transcriptional pattern of M2\/alternatively activated macrophages","volume":"192","author":"Desnues","year":"2005","journal-title":"J Infect Dis"},{"key":"R17-20250728","first-page":"4575","article-title":"IL-16 is critical for Tropheryma whipplei replication in Whipple's disease","volume":"175","author":"Desnues","year":"2005","journal-title":"J Immunol Baltim Md 1950"},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"667357","DOI":"10.3389\/fimmu.2021.667357","article-title":"Tumor necrosis factor inhibitors exacerbate Whipple's disease by reprogramming macrophage and inducing apoptosis","volume":"12","author":"Boumaza","year":"2021","journal-title":"Front Immunol"},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S1473-3099(15)00537-X","article-title":"Tropheryma whipplei infection and Whipple's disease","volume":"16","author":"Marth","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"R20-20250728","doi-asserted-by":"crossref","first-page":"e0145722","DOI":"10.1128\/jcm.01457-22","article-title":"Contribution of PCR to differential diagnosis between patients with Whipple disease and Tropheryma whipplei carriers","volume":"61","author":"Meyer","year":"2023","journal-title":"J Clin Microbiol"},{"key":"R21-20250728","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/infdis\/jir219","article-title":"An experimental mouse model to establish Tropheryma whipplei as a diarrheal agent","volume":"204","author":"Al Moussawi","year":"2011","journal-title":"J Infect Dis"},{"key":"R22-20250728","doi-asserted-by":"crossref","first-page":"e1000722","DOI":"10.1371\/journal.ppat.1000722","article-title":"Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei","volume":"6","author":"Al Moussawi","year":"2010","journal-title":"PLoS Pathog"},{"key":"R23-20250728","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J Exp Med"},{"key":"R24-20250728","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00006","article-title":"Treatment of refractory Whipple disease with interferon-gamma","volume":"129","author":"Schneider","year":"1998","journal-title":"Ann Intern Med"},{"key":"R25-20250728","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13256-015-0632-6","article-title":"Whipple's disease diagnosed during antitumor necrosis factor alpha treatment: two case reports and review of the literature","volume":"9","author":"Ramos","year":"2015","journal-title":"J Med Case Rep"},{"key":"R26-20250728","doi-asserted-by":"crossref","first-page":"e250693","DOI":"10.1136\/bcr-2022-250693","article-title":"Whipple's disease unmasked by TNF inhibitor therapy for treatment of seronegative rheumatoid arthritis","volume":"15","author":"Mohammed","year":"2022","journal-title":"BMJ Case Rep"},{"key":"R27-20250728","doi-asserted-by":"crossref","first-page":"e261968","DOI":"10.1136\/bcr-2024-261968","article-title":"Classic Whipple disease presenting as genuine pyrexia of unknown origin following immunosuppression with adalimumab","volume":"17","author":"Al-Musawi","year":"2024","journal-title":"BMJ Case Rep"},{"key":"R28-20250728","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/apt.13140","article-title":"Systematic review: Whipple's disease (Tropheryma whipplei infection) and its unmasking by tumour necrosis factor inhibitors","volume":"41","author":"Marth","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-20250728","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1016\/j.cell.2022.07.004","article-title":"From rare disorders of immunity to common determinants of infection: following the mechanistic thread","volume":"185","author":"Casanova","year":"2022","journal-title":"Cell"},{"key":"R30-20250728","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-micro-092123-022855","article-title":"The microbe, the infection enigma, and the host","author":"Casanova","year":"2024","journal-title":"Annu Rev Microbiol"},{"key":"R31-20250728","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.immuni.2024.05.020","article-title":"Human determinants of age-dependent patterns of death from infection","volume":"57","author":"Abel","year":"2024","journal-title":"Immunity"},{"key":"R32-20250728","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9343(55)90127-3","article-title":"Whipple's disease","volume":"19","author":"Puite","year":"1955","journal-title":"Am J Med"},{"key":"R33-20250728","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0016-5085(59)80097-4","article-title":"Whipple's disease; report of four cases, including two in brothers, with observations on pathologic physiology, diagnosis, and treatment","volume":"36","author":"Gross","year":"1959","journal-title":"Gastroenterology"},{"key":"R34-20250728","first-page":"842","article-title":"[Whipple's disease: study of 3 cases and epidemiological and radiological remarks]","volume":"20","author":"Capron","year":"1975","journal-title":"Lille Med J Fac Med Pharm Univ Lille"},{"key":"R35-20250728","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jac\/dkr032","article-title":"Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease","volume":"66","author":"Lagier","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R36-20250728","first-page":"1294","article-title":"Lack of association with spondyloarthritis and HLA-B27 in Italian patients with Whipple's disease","volume":"28","author":"Olivieri","year":"2001","journal-title":"J Rheumatol"},{"key":"R38-20250728","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2023.11.036","article-title":"Human inherited CCR2 deficiency underlies progressive polycystic lung disease","volume":"187","author":"Neehus","year":"2024","journal-title":"Cell"},{"key":"R39-20250728","doi-asserted-by":"crossref","first-page":"5114","DOI":"10.1016\/j.cell.2023.09.024","article-title":"Human MCTS1-dependent translation of JAK2 is essential for IFN-\u03b3 immunity to mycobacteria","volume":"186","author":"Bohlen","year":"2023","journal-title":"Cell"},{"key":"R40-20250728","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.cell.2020.10.046","article-title":"Human T-bet governs innate and innate-like adaptive IFN-\u03b3 immunity against mycobacteria","volume":"183","author":"Yang","year":"2020","journal-title":"Cell"},{"key":"R41-20250728","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.cell.2022.12.038","article-title":"Human IRF1 governs macrophagic IFN-\u03b3 immunity to mycobacteria","volume":"186","author":"Rosain","year":"2023","journal-title":"Cell"},{"key":"R42-20250728","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00439-020-02120-y","article-title":"Mendelian susceptibility to mycobacterial disease: recent discoveries","volume":"139","author":"Bustamante","year":"2020","journal-title":"Hum Genet"},{"key":"R43-20250728","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1172\/JCI135460","article-title":"Inherited human IFN-gamma deficiency underlies mycobacterial disease","volume":"130","author":"Kerner","year":"2020","journal-title":"J Clin Invest"},{"key":"R44-20250728","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41586-024-07866-3","article-title":"Tuberculosis in otherwise healthy adults with inherited TNF deficiency","volume":"633","author":"Arias","year":"2024","journal-title":"Nature"},{"key":"R45-20250728","doi-asserted-by":"crossref","first-page":"e32340","DOI":"10.7554\/eLife.32340","article-title":"IRF4 haploinsufficiency in a family with Whipple's disease","volume":"7","author":"Gu\u00e9rin","year":"2018","journal-title":"eLife"},{"key":"R46-20250728","article-title":"IRF4 haploinsufficiency in a multiplex family with Whipple's arthritis","author":"Unal","year":"2024","journal-title":"Advance"},{"key":"R47-20250728","doi-asserted-by":"crossref","first-page":"eade7953","DOI":"10.1126\/sciimmunol.ade7953","article-title":"A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency","volume":"8","author":"Fornes","year":"2023","journal-title":"Sci Immunol"},{"key":"R48-20250728","doi-asserted-by":"crossref","first-page":"e20221292","DOI":"10.1084\/jem.20221292","article-title":"A neomorphic mutation in the interferon activation domain of IRF4 causes a dominant primary immunodeficiency","volume":"220","author":"Thouenon","year":"2023","journal-title":"J Exp Med"},{"key":"R49-20250728","doi-asserted-by":"crossref","first-page":"e20231044","DOI":"10.1084\/jem.20231044","article-title":"Helper T cell immunity in humans with inherited CD4 deficiency","volume":"221","author":"Gu\u00e9rin","year":"2024","journal-title":"J Exp Med"},{"key":"R50-20250728","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/infdis\/jiab025","article-title":"Lost in translation: lack of CD4 expression due to a novel genetic defect","volume":"223","author":"Lisco","year":"2021","journal-title":"J Infect Dis"},{"key":"R51-20250728","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3389\/fimmu.2019.02502","article-title":"Complete multilineage CD4 expression defect associated with warts due to an inherited homozygous CD4 gene mutation","volume":"10","author":"Fernandes","year":"2019","journal-title":"Front Immunol"},{"key":"R52-20250728","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41590-024-01815-y","article-title":"The ouroboros of autoimmunity","volume":"25","author":"Casanova","year":"2024","journal-title":"Nat Immunol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:00:36Z","timestamp":1753722036000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001088","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]}}}